Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1639228
Reference Type
Journal Article
Title
An approach for integrating toxicogenomic data in risk assessment: The dibutyl phthalate case study
Author(s)
Euling, SY; Thompson, CM; Chiu, WA; Benson, R
Year
2013
Is Peer Reviewed?
1
Journal
Toxicology and Applied Pharmacology
ISSN:
0041-008X
EISSN:
1096-0333
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Location
SAN DIEGO
Volume
271
Issue
3
Page Numbers
324-335
Language
English
PMID
23537663
DOI
10.1016/j.taap.2013.03.013
Web of Science Id
WOS:000324669500004
URL
https://search.proquest.com/docview/1746326515?accountid=171501
Exit
Abstract
An approach for evaluating and integrating genomic data in chemical risk assessment was developed based on the lessons learned from performing a case study for the chemical dibutyl phthalate. A case study prototype approach was first developed in accordance with EPA guidance and recommendations of the scientific community. Dibutyl phthalate (DBP) was selected for the case study exercise. The scoping phase of the dibutyl phthalate case study was conducted by considering the available DBP genomic data, taken together with the entire data set, for whether they could inform various risk assessment aspects, such as toxicodynamics, toxicokinetics, and dose-response. A description of weighing the available dibutyl phthalate data set for utility in risk assessment provides an example for considering genomic data for future chemical assessments. As a result of conducting the scoping process, two questions-Do the DBP toxicogenomic data inform 1) the mechanisms or modes of action?, and 2) the interspecies differences in toxicodynamics?-were selected to focus the case study exercise. Principles of the general approach include considering the genomics data in conjunction with all other data to determine their ability to inform the various qualitative and/or quantitative aspects of risk assessment, and evaluating the relationship between the available genomic and toxicity outcome data with respect to study comparability and phenotypic anchoring. Based on experience from the DBP case study, recommendations and a general approach for integrating genomic data in chemical assessment were developed to advance the broader effort to utilize 21st century data in risk assessment.
Keywords
Phthalates; Toxicogenomic; Risk assessment; Endocrine disrupting chemical; Male development; Testosterone
Tags
•
Dibutyl Phthalate (DBP)
Database Searches
Pubmed
Web of Science
LitSearch Dec 2012 - June 2013
PubMed
LitSearch June 2013 – Jan 2014
PubMed
Web of Science
Secondary Literature
Reviews and Editorials
Risk assessments
•
Phthalates – Targeted Search for Epidemiological Studies
Source – all searches
Pubmed
Excluded
Source - Dec 2013 Update (Private)
Pubmed
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity